Skip to content
Screener

Bruker BRKR Energy And Supercon Technologies — Research And Development Expense

Other segment segments

Bsi Nano
$39.2M-11.7%
Bsi Calid
$32.6M+8.7%
Bsi Biospin
$21.5M-7.3%

Similar metrics at other companies

Chemours logo
CCTitanium Technologies — Research And Development Expense
$7M-12.5%
Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Viasat logo
VSATDefense And Advanced Technologies — Research And Development Expense
$17.1M+14.0%
Novanta logo
NOVTAutomation Enabling Technologies — Research And Development Expense
$9.5M+2.4%
KULR Technology Group logo
KULREnergy Management Platform — Research And Development Expense
$1.77M-27.7%
Ultralife logo
ULBIBattery Energy Products — Research And Development Expense
$2.3M+54.1%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.99B+71.7%
Enterprise value$9.62B+37.7%
P/S2.3×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Bruker’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335226
Line itemThree Months Ended June 30, 2026 / BSI Bio SpinThree Months Ended June 30, 2026 / BSI CALIDThree Months Ended June 30, 2026 / BSI NANOThree Months Ended June 30, 2026 / BESTThree Months Ended June 30, 2026 / TotalThree Months Ended June 30, 2025 / BSI Bio SpinThree Months Ended June 30, 2025 / BSI CALIDThree Months Ended June 30, 2025 / BSI NANOThree Months Ended June 30, 2025 / BESTThree Months Ended June 30, 2025 / Total
Segment expenses:
Cost of revenue$94.1$126.1$123.7$59.8$403.7$108.1$125.6$125.6$52.3$411.6
Selling, general and administrative38.479.368.65.8192.140.976.972.75.7196.2
Research and development21.532.639.21.094.323.230.044.41.198.7
Segment operating income$41.7$72.3$29.8$7.6$151.4$23.1$53.3$9.4$7.2$93.0
Reconciliation of Total operating income:
Corporate, elimination and other (a)$32.8$21.1
Adjustments and reconciling items (b)183.960.0

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's energy and supercon technologies — research and development expense?
Bruker (BRKR) reported energy and supercon technologies — research and development expense of $1M in Q2 2026.
How has Bruker's energy and supercon technologies — research and development expense changed year-over-year?
Bruker's energy and supercon technologies — research and development expense decreased by 9.1% year-over-year, from $1.1M to $1M.
What is the long-term trend for Bruker's energy and supercon technologies — research and development expense?
Over 3 years (2022 to 2025), Bruker's energy and supercon technologies — research and development expense has grown at a 10.8% compound annual growth rate (CAGR), from $2.5M to $3.4M.
What does energy and supercon technologies — research and development expense mean?
Represents the costs incurred by the Energy and Supercon Technologies segment to develop new products, improve existing technologies, and conduct scientific research. This investment is critical for maintaining the segment's competitive position in specialized energy and superconductivity markets.

Ask your AI about Bruker's energy and supercon technologies — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude